Goldman Sachs’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $878K | Sell |
116,135
-14,275
| -11% | -$108K | ﹤0.01% | 3924 |
|
|
2025
Q1 | $720K | Buy |
130,410
+6,549
| +5% | +$36.2K | ﹤0.01% | 4032 |
|
|
2024
Q4 | $712K | Sell |
123,861
-36,272
| -23% | -$209K | ﹤0.01% | 4112 |
|
|
2024
Q3 | $1.66M | Buy |
160,133
+75,322
| +89% | +$780K | ﹤0.01% | 3493 |
|
|
2024
Q2 | $1.1M | Sell |
84,811
-5,879
| -6% | -$76.3K | ﹤0.01% | 3533 |
|
|
2024
Q1 | $1.58M | Sell |
90,690
-95,951
| -51% | -$1.68M | ﹤0.01% | 3337 |
|
|
2023
Q4 | $1.76M | Sell |
186,641
-105,286
| -36% | -$991K | ﹤0.01% | 3296 |
|
|
2023
Q3 | $3.26M | Buy |
291,927
+52,858
| +22% | +$590K | ﹤0.01% | 2775 |
|
|
2023
Q2 | $5.12M | Buy |
239,069
+8,979
| +4% | +$192K | ﹤0.01% | 2557 |
|
|
2023
Q1 | $9.3M | Sell |
230,090
-5,356
| -2% | -$217K | ﹤0.01% | 2066 |
|
|
2022
Q4 | $11M | Buy |
235,446
+60,851
| +35% | +$2.83M | ﹤0.01% | 2064 |
|
|
2022
Q3 | $9.06M | Buy |
174,595
+36,239
| +26% | +$1.88M | ﹤0.01% | 2211 |
|
|
2022
Q2 | $6.54M | Buy |
138,356
+37,855
| +38% | +$1.79M | ﹤0.01% | 2449 |
|
|
2022
Q1 | $7.15M | Sell |
100,501
-19,150
| -16% | -$1.36M | ﹤0.01% | 2512 |
|
|
2021
Q4 | $8.95M | Buy |
119,651
+17,319
| +17% | +$1.3M | ﹤0.01% | 2363 |
|
|
2021
Q3 | $5.81M | Sell |
102,332
-41,099
| -29% | -$2.34M | ﹤0.01% | 2683 |
|
|
2021
Q2 | $6.31M | Buy |
143,431
+7,502
| +6% | +$330K | ﹤0.01% | 2609 |
|
|
2021
Q1 | $6.7M | Sell |
135,929
-25,485
| -16% | -$1.26M | ﹤0.01% | 2469 |
|
|
2020
Q4 | $6.8M | Sell |
161,414
-175,512
| -52% | -$7.39M | ﹤0.01% | 2287 |
|
|
2020
Q3 | $15.4M | Sell |
336,926
-26,822
| -7% | -$1.23M | ﹤0.01% | 1656 |
|
|
2020
Q2 | $18.3M | Sell |
363,748
-6,073
| -2% | -$305K | 0.01% | 1530 |
|
|
2020
Q1 | $19M | Buy |
369,821
+34,988
| +10% | +$1.8M | 0.01% | 1357 |
|
|
2019
Q4 | $20.7M | Buy |
334,833
+61,509
| +23% | +$3.8M | 0.01% | 1587 |
|
|
2019
Q3 | $16.4M | Buy |
273,324
+96,787
| +55% | +$5.81M | ﹤0.01% | 1648 |
|
|
2019
Q2 | $14.9M | Buy |
176,537
+32,473
| +23% | +$2.74M | ﹤0.01% | 1744 |
|
|
2019
Q1 | $13.8M | Sell |
144,064
-75,173
| -34% | -$7.18M | ﹤0.01% | 1839 |
|
|
2018
Q4 | $15.5M | Buy |
219,237
+61,638
| +39% | +$4.37M | ﹤0.01% | 1680 |
|
|
2018
Q3 | $13.5M | Buy |
157,599
+36,904
| +31% | +$3.15M | ﹤0.01% | 1879 |
|
|
2018
Q2 | $14M | Sell |
120,695
-38,513
| -24% | -$4.46M | ﹤0.01% | 1836 |
|
|
2018
Q1 | $12.9M | Buy |
159,208
+48,904
| +44% | +$3.96M | ﹤0.01% | 1786 |
|
|
2017
Q4 | $6.47M | Buy |
110,304
+26,269
| +31% | +$1.54M | ﹤0.01% | 2145 |
|
|
2017
Q3 | $3.93M | Buy |
84,035
+331
| +0.4% | +$15.5K | ﹤0.01% | 2505 |
|
|
2017
Q2 | $3.01M | Buy |
83,704
+25,154
| +43% | +$905K | ﹤0.01% | 2559 |
|
|
2017
Q1 | $1.8M | Sell |
58,550
-23,799
| -29% | -$733K | ﹤0.01% | 2802 |
|
|
2016
Q4 | $2.76M | Buy |
82,349
+61,136
| +288% | +$2.05M | ﹤0.01% | 2517 |
|
|
2016
Q3 | $564K | Buy |
+21,213
| New | +$564K | ﹤0.01% | 3376 |
|
|
2016
Q2 | – | Sell |
-7,923
| Closed | -$233K | – | 4542 |
|
|
2016
Q1 | $233K | Sell |
7,923
-11,668
| -60% | -$343K | ﹤0.01% | 3684 |
|
|
2015
Q4 | $647K | Buy |
+19,591
| New | +$647K | ﹤0.01% | 3115 |
|
|
2015
Q3 | – | Sell |
-31,059
| Closed | -$1.4M | – | 4595 |
|
|
2015
Q2 | $1.4M | Sell |
31,059
-13,438
| -30% | -$604K | ﹤0.01% | 2771 |
|
|
2015
Q1 | $1.36M | Sell |
44,497
-90,534
| -67% | -$2.77M | ﹤0.01% | 2742 |
|
|
2014
Q4 | $6.87M | Buy |
135,031
+87,564
| +184% | +$4.45M | ﹤0.01% | 1797 |
|
|
2014
Q3 | $1.88M | Buy |
47,467
+42,468
| +850% | +$1.68M | ﹤0.01% | 2552 |
|
|
2014
Q2 | $215K | Buy |
+4,999
| New | +$215K | ﹤0.01% | 3937 |
|
|
2014
Q1 | – | Sell |
-9,541
| Closed | -$260K | – | 4336 |
|
|
2013
Q4 | $260K | Sell |
9,541
-40
| -0.4% | -$1.09K | ﹤0.01% | 3766 |
|
|
2013
Q3 | $220K | Sell |
9,581
-4,093
| -30% | -$94K | ﹤0.01% | 3783 |
|
|
2013
Q2 | $242K | Buy |
+13,674
| New | +$242K | ﹤0.01% | 3540 |
|